Polymerase Chain Reaction (PCR) Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033

The PCR Market Report Overview

The PCR market size was $700.3 million in 2023. Factors such as recent technological advances will drive the market growth at a CAGR of more than 5% from 2023 to 2033.

Polymerase Chain Reaction (PCR) systems are used for nucleic acid amplification. They are commonly employed in investigations related to the diagnosis or prognosis of cancer or infectious diseases. The Polymerase chain reaction (PCR) is a method used to amplify short DNA or RNA sequences in a sample. This process is carried out with small quantities of RNA or DNA. It involves repeated heating and cooling of nucleic acids. Recombinant enzymes are combined in the process to mimic natural DNA repair in cells.

PCR Market Outlook 2023-2033 ($ Million)

Buy the Full Report for More Insights on the PCR Market Forecast, Download a Free Sample Report

The PCR market research report identifies quantitative market trends within In-Vitro Diagnostics  therapeutic areas. The report offers regional quantitative and qualitative data highlighting the sales in major markets. The model also covers in detail the effects of COVID-19 on the PCR market for 2020 and beyond. Furthermore, the report provides PCR market share by a company that will help in identifying untapped market opportunities.

PCR Market Segments

The key segments of the PCR market are automated qPCR systems, digital PCR systems, and semi-automated qPCR systems. In 2023, automated qPCR systems led the market.

Automated qPCR Systems are those PCR systems that require no sample preparation or separate extraction. These systems contain prefilled reagents/cartridges required to amplify the DNA/RNA samples.

Semi-automated qPCR Systems are systems for Polymerase Chain Reactions that need extra steps for liquid handling. Additionally, these systems require assistance for sample pipetting and plate sealing. One unit refers to one Semi-Automated qPCR System.

PCR Market Analysis by Segments, 2023 (%)

Buy the Full Report for More Segment-Wise into the Insights PCR Market, Download a Free Sample Report

Regional Analysis of the PCR Market

The key regions in the PCR market are Asia-Pacific, Europe, the Middle East, and Africa. North America and South and Central America are other leading regional markets. In 2023, the North American PCR market was the leading regional segment.

Increased prevalence of cancer cases, increased incidence of multiple infectious diseases, and a growing preference amongst physicians for precision medicine will drive the growth of the North American PCR systems market

PCR Market Analysis by Regions, 2023 (%)

Buy the Full Report for More Regional Insights into the PCR Market, Download A Free Sample Report

PCR Market – Competitive Landscape

In 2023, Bio-Rad Laboratories Inc.’s PCR market share was the highest

The major players in the PCR market are:

• F. Hoffmann-La Roche Ltd
• Bio-Rad Laboratories Inc
• Thermo Fisher Scientific Inc
• Qiagen NV
• Abbott Laboratories

As a competitive strategy, companies may wish to invest in training and education schemes. This can promote awareness of relevant diseases, such as cervical cancer, in countries that have the potential to implement more comprehensive national screening strategies. Additionally, these programs can familiarize physicians with a company’s brand or type of device. In addition, companies may want to collaborate with government agencies, independent distributors, and physician associations to ensure their device is used in national screening programs. These programs have the potential to generate large sales volumes.

PCR Market Analysis by Companies, 2023 (%)

Buy the Full Report for More Company-Wise Insights into the PCR Market, Download a Free Sample Report

PCR Market Dynamics

• Trends: The market for PCR systems is increasing due to their reliability, advanced amplification technology, and fast testing mechanisms. In both developed and developing countries, PCR systems are installed in hospital and reference laboratory settings. Primary research participants indicate that these machines are typically purchased outright rather than being rented or leased. During the forecast period, revenue is expected to be driven primarily by automated PCR systems and dPCR systems.

• Future Outlook: GlobalData predicts the PCR systems market to remain strong during the forecast period. In many countries, hospitals and medical laboratories are getting consolidated due to economic pressures. This consolidation is driven by the increased demand for high-volume lab testing in routine diagnostic procedures.

Purchase the Complete Report for Additional Insights on the PCR Market Dynamics, Get a Free Sample Report Here

Segments Covered in this Report.

PCR Market Segment Outlook ($ Million, 2015-2033)

• Automated qPCR Systems
• Digital PCR Systems
• Semi-automated qPCR Systems

PCR Regional Outlook ($ Million, 2015-2033)

• Asia-Pacific
• Europe
• Middle East and Africa
• North America
• South and Central America

Key Inclusions of the market model are:

The PCR market research report includes an insightful review of the key industry trends.

• The PCR market report offers an annualized market revenue by segment and market outlooks from 2015-2033.
• The report also includes market-level data on units, average selling prices, and market values.

Regional, Country, and Global PCR Market Insights:

• The PCR market share report offers qualitative insights into global and regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
• PCR market SWOT analysis.
• The report provides trends and PCR market competitive dynamics.

Buy the Full Report for More Insights on the PCR Market Share, Download a Free Sample Report

Learn about consumer behavior through the detailed overview of segments and the healthcare system. The report also offers information on reimbursement policies and the regulatory landscape.

• Country-specific overview of the healthcare system.
• Country-specific reimbursement policies.
• Country-specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. These syndicated models include demand and supply-side primary sources including Key opinion leaders. In addition, determine market trends through real-world data sources including databases of government procedures and hospital purchasing.

Companies Covered: F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Thermo Fisher Scientific Inc, Qiagen NV, Abbott Laboratories, bioMerieux Inc, Becton Dickinson and Co, Siemens AG, Danaher Corp, Standard BioTools Inc, Hologic Inc, and Others.

Countries Covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

• Extensive coverage of the PCR market under development.
• An exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
• Reviews of major players involved in the development of the PCR market and lists all their pipeline projects.
• Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
• Key clinical trial data of ongoing clinical trials specific to pipeline products.
• Recent developments in the segment/industry.

Reasons to Buy

• Understand the COVID-19 impact on PCR.
• Design your licensing strategies through a review of products, technologies, and companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving PCR.
• Understand the trends, innovative product launches, technologies, segments, and companies that will impact the market in the future.
• Formulate effective sales and marketing strategies with a detailed evaluation of PCR’s market share by company. Identify strong competitors and create winning strategies to stand out in the global PCR market.
• Track regional PCR market sales as well as country-specific transactions from 2015-2033.
• Organize your sales and marketing efforts by identifying the global PCR market segments that present maximum opportunities. Such details will help to make investments and strategic partnerships.